Christoph D. Spinner
TUM Klinikum(DE)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, HIV/AIDS Research and Interventions, Long-Term Effects of COVID-19, HIV/AIDS drug development and treatment
Most-Cited Works
- → Remdesivir for 5 or 10 Days in Patients with Severe Covid-19(2020)1,431 cited
- → Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19(2020)1,265 cited
- → Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials(2018)373 cited
- → COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients(2020)245 cited
- → HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans(2015)244 cited
- → Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV(2020)166 cited
- → Clinical and virological features of first human monkeypox cases in Germany(2022)150 cited
- → Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship(2020)147 cited
- → Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study(2016)129 cited
- → Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany(2022)108 cited